Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

J Clin Oncol. 2015 Apr 10;33(11):1297-8. doi: 10.1200/JCO.2014.59.2808. Epub 2015 Mar 9.

Authors

Pelagia G Tsoutsou¹, Jean Bourhis², George Coukos³

Affiliations

¹ Hôpital du Valais-Centre Hospitalier du Valais Romand, Hôpital de Sion, Sion; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
² Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
³ Centre Hospitalier Universitaire Vaudois and Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland george.coukos@chuv.ch.

PMID: 25753438
DOI: 10.1200/JCO.2014.59.2808

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / analysis*
Female
Humans
Lymphocytes, Tumor-Infiltrating*
Triple Negative Breast Neoplasms / pathology*

Substances

Biomarkers, Tumor